SCRS Corporate Partnerships
Global Impact Partners
The SCRS Global Impact Partner (GIP) program offers industry sponsors, CROs, service providers and research sites an opportunity to align with SCRS’ mission of ensuring site sustainability.
This unique partnership allows industry leadership to provide input on strategic initiatives for the organization and contribute to SCRS events, committees, publications, advocacy and education for research sites.
Through this collaboration, GIPs gain a deeper understanding of the needs of research sites and take part in the development of site-focused solutions within the clinical research marketplace.

Circle of Innovation Partner

Circle of Sustainability Partner

Site Voice Partner

Site Engagement Partner

Global Impact Partners
CRO
Site
Epic Medical Research is a physician-owned, multi-specialty clinical research network committed to advancing medicine. Since 2020, we have conducted over 140 clinical research studies Epic Medical Research is a physician-owned, multi-specialty clinical research network committed to advancing medicine. Since 2020, we have conducted over 140 clinical research studies across 15 facilities in five states, delivering top-tier data and unmatched enrollment performance., delivering top-tier data and unmatched enrollment performance.
We proudly serve diverse communities — including Native American, African American, Hispanic, rural, and LGBTQIA+ populations — ensuring that clinical research reflects the people it aims to help. www.epicmedresearch.com.
Headlands Research is a multinational integrated clinical trial site organization with a focus on large-volume recruitment and retention of diverse, inclusive populations through extensive site databases and physician partnerships. www.headlandsresearch.com.
Pratia is a global network of clinical research sites built to bring trials closer to patients. Rather than following traditional site models, Pratia partners with local healthcare providers and key opinion leaders to embed research capabilities directly into real-world care settings, whether through integrated or dedicated site models.
Their flexible, scalable approach means clinical trials can reach more patients, in more places, without sacrificing quality. For sites, that translates to a partner that understands the operational realities of research delivery and is invested in making it work at the community level. www.pratia.com.
Revival Research Institute is an independent clinical research site network headquartered in Michigan, with a growing presence across Texas, Illinois, North Carolina, Georgia, and Nebraska. Conducting outpatient clinical trials across a wide range of therapeutic areas, Revival works closely with sponsors, CROs, and patients to advance medicine with purpose and speed.
With a patient-first philosophy at the core of everything they do, Revival’s experienced site teams are built to deliver clean, submission-ready data on aggressive timelines without compromising the patient experience. Their operations are designed for efficiency, from rapid startup through recruitment, retention, and data integrity, giving sponsors both the consistency of a scalable network and the responsiveness of a site-level team. www.revivalresearch.org.

Solution Provider
Ledger Run is a purpose-built clinical trial financial operations platform that unifies contract negotiation, site budgeting, payments, and financial forecasting in a single system. Backed by in-country legal experts across 65+ countries, Ledger Run delivers local-language contracting, fair market value-based budget development, and just-in-time site payments that keep studies on schedule, including in complex transitions and rescue scenarios.
Built by industry experts who have worked alongside the largest sponsors and CROs, Ledger Run brings transparency and efficiency to every stage of the trial financial process, from CTA to pay. www.ledgerrun.com.
Sponsor
Zenas BioPharma is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for patients living with autoimmune diseases. Led by a veteran team of biopharmaceutical leaders with a proven track record in drug development, commercialization, and corporate strategy, Zenas is focused on bringing more treatment options and scientific innovation to the patients who need them most.
Driven by a shared commitment to operational excellence and nimble execution, the Zenas team combines diverse expertise with a values-driven approach to advancing meaningful therapies from development to reality.
For more information on Zenas BioPharma, visit www.zenasbio.comGlobal Impact Partners
The SCRS Global Impact Partner (GIP) program connects pharmaceutical sponsors, CROs, and service providers directly with the clinical research site community. GIPs provide input on strategic initiatives and collaborate on developing site-focused solutions, gaining a deeper understanding of site needs and helping shape the future of clinical research.
• Shape clinical research industry initiatives
• Support site sustainability and success
• Support site sustainability and success

